Key points are not available for this paper at this time.
Summary Self-assembled coordination architectures are emerging as powerful platforms for creating artificial enzymes that emulate the structural and functional complexity of natural biocatalysts. By combining well-defined cavities, tunable host-guest interactions, and catalytic control within confined nanoscale spaces, these systems offer unique opportunities for advancing sustainable catalysis, molecular recognition, and biomedical innovation. In this perspective, we highlight recent advances in the design and function of coordination-driven artificial enzymes, focusing on how metal-organic architectures (MOAs) can be engineered to stabilize reactive intermediates, direct substrate selectivity, and respond to external stimuli. We outline the principles behind these supramolecular systems and explore their growing potential in both industrial and therapeutic contexts.
Bajer et al. (Tue,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: